Skyline Medical Inc. (SKLND) Financials Nov 14, 20
Post# of 250675
Posted On: 11/17/2014 3:18:52 AM
Skyline Medical Inc. (SKLND) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Skyline Medical Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 15,737 288 96,637 188,772 468,125
Cost of Goods Sold (COGS) incl. D&A 7,000 2,569 56,080 128,540 189,707
COGS excluding D&A 3,958 140 52,905 127,461 181,534
Depreciation & Amortization Expense 3,042 2,429 3,175 1,079 8,173
Depreciation 3,042 2,429 3,175 - 8,173
Amortization of Intangibles 0 0 0 - 0
Gross Income 8,737 (2,281) 40,557 60,232 278,418
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 2.01M 2.07M 4.15M 7.22M 9.07M
Research & Development 0 0 0 761,047 235,000
Other SG&A 2.01M 2.07M 4.15M 6.46M 8.83M
Other Operating Expense 447,000 276,998 0 0 0
Unusual Expense 369,642 (1.15M) 151,118 3,116 (16,992)
EBIT after Unusual Expense (369,642) 1.15M (151,118) (3,116) 16,992
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 78,938 147,093 230,374 259,349 636,503
Gross Interest Expense 78,938 147,093 230,374 259,349 636,503
Interest Capitalized 0 0 0 0 0
Pretax Income (2.89M) (1.35M) (4.49M) (7.42M) (9.41M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (2.89M) (1.35M) (4.49M) (7.42M) (9.41M)
Minority Interest Expense 0 0 0 0 0
Net Income (2.89M) (1.35M) (4.49M) (7.42M) (9.41M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (2.89M) (1.35M) (4.49M) (7.42M) (9.41M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (2.89M) (1.35M) (4.49M) (7.42M) (9.41M)
EPS (Basic) (23.25) (8.25) (13.50) - (4.50)
Basic Shares Outstanding 126,338 170,289 323,766 - 2.03M
EPS (Diluted) (23.25) (8.25) (13.50) - (4.50)
Diluted Shares Outstanding 126,338 170,289 323,766 - 2.03M
EBITDA (2.44M) (2.35M) (4.1M) (7.16M) (8.78M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Skyline Medical Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 15,737 288 96,637 188,772 468,125
Cost of Goods Sold (COGS) incl. D&A 7,000 2,569 56,080 128,540 189,707
COGS excluding D&A 3,958 140 52,905 127,461 181,534
Depreciation & Amortization Expense 3,042 2,429 3,175 1,079 8,173
Depreciation 3,042 2,429 3,175 - 8,173
Amortization of Intangibles 0 0 0 - 0
Gross Income 8,737 (2,281) 40,557 60,232 278,418
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 2.01M 2.07M 4.15M 7.22M 9.07M
Research & Development 0 0 0 761,047 235,000
Other SG&A 2.01M 2.07M 4.15M 6.46M 8.83M
Other Operating Expense 447,000 276,998 0 0 0
Unusual Expense 369,642 (1.15M) 151,118 3,116 (16,992)
EBIT after Unusual Expense (369,642) 1.15M (151,118) (3,116) 16,992
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 78,938 147,093 230,374 259,349 636,503
Gross Interest Expense 78,938 147,093 230,374 259,349 636,503
Interest Capitalized 0 0 0 0 0
Pretax Income (2.89M) (1.35M) (4.49M) (7.42M) (9.41M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (2.89M) (1.35M) (4.49M) (7.42M) (9.41M)
Minority Interest Expense 0 0 0 0 0
Net Income (2.89M) (1.35M) (4.49M) (7.42M) (9.41M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (2.89M) (1.35M) (4.49M) (7.42M) (9.41M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (2.89M) (1.35M) (4.49M) (7.42M) (9.41M)
EPS (Basic) (23.25) (8.25) (13.50) - (4.50)
Basic Shares Outstanding 126,338 170,289 323,766 - 2.03M
EPS (Diluted) (23.25) (8.25) (13.50) - (4.50)
Diluted Shares Outstanding 126,338 170,289 323,766 - 2.03M
EBITDA (2.44M) (2.35M) (4.1M) (7.16M) (8.78M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)